Navigation Links
Patient Self-Monitoring: Devices, Markets, Players and Prospects
Date:10/19/2011

t potential, commercialization risks and opportunities

• Examines next-generatione monitor technologies, design issues and evolving market factors

• Provides forecasts and market data for self-monitoring products to 2015

• Assesses the impact and influence of self-monitoring enhancements on the healthcare management market

• Profiles self-monitoring market participants, their technology, product development activity, and business strategies

Executive Summary

Disease Management Market Dynamics

Patient Monitoring Overview

Key Factors in Patient Compliance

Market Drivers

Shifting Patient Demographics

Industry Alignment and Competitive Landscape

Self-Monitoring Technology Strategies

Needle-Stick Tests

Dry Chemistry Test Strips

Cassettes

Meters

Self-Collected / Mail-in Tests

Combination Meters

Continuous Monitors

Future Developments

Noninvasive Monitors

Technologies

Optical

Energy-based

Thermal

Signal Processing Advances

Monitor Product Design & Patient Issues

Reliability

Measurement Frequency

Patient/User Interface

Ease-of-Use

Data Collection/Data Display

Continuous vs Discrete Monitoring

Measurement Electronics

Calibration

Accuracy/Precision

Sensitivity

Sensor Technology

Self-Monitoring Therapeutic Segments

Atherosclerosis/Heart Disease (Cholesterol)

Total Cholesterol

Triclycerides

Cholesterol Panel/Lipid Profile

Diabetes (Glucose)

OTC Meters

Alternate Site Testing

Continuous Monitoring

Heart Valve Replacement/Thrombosis

Oral Anticoagulation Therapy

Prothrombin Time

Hypertension (Blood Pressure)

Oscillometric Measurements

Demographic Trends

Self-Monitoring Product Segmen
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015  ResMed Inc. (NYSE: RMD ) today announced ... the quarter was $423.0 million, a 10 percent increase compared ... increase on a constant currency basis). Net income was $91.2 ... ended December 31, 2013. Diluted earnings per share for the ...
(Date:1/22/2015)... Jan. 22, 2015  Amgen (NASDAQ: AMGN ) today announced ... financial results on Tuesday, Jan. 27, 2015, after the close of ... conference call with the investment community at 2 p.m. PT. Participating ... , chairman and chief executive officer, and other members of Amgen,s ...
(Date:1/22/2015)... 2015  Profil Institute for Clinical Research, Inc., a clinical ... today a new textbook,  Translational Research Methods for Diabetes, ... leading global scientific publisher. The textbook is ... use in early phase clinical studies of new drugs ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David ... Show to bestow a Juvent Sports Achievement award upon ... McKitrick. The award commemorated and congratulated McKitrick for her ... won her first amateur tournament in 1979 and most ...
(Date:1/22/2015)... 22, 2015 For over 20 years, Dr. David ... and Vista area has treated just about every type of ... circumstances. And for those same twenty-plus years, the team at ... those injuries with the best possible doctor. With the ...
(Date:1/22/2015)... 22, 2015 Yesterday, Senator Holly ... and Kristin Olsen (R-Modesto) were honored by the ... advancing biotechnology, biomedical science, medical device and pharmaceutical ... received the “2014 Life Sciences Champion” award from ...
(Date:1/22/2015)... Payday lending practices in four southern states worsen ... to the states that permit them, according to a ... Race and Wealth. , While they generate hundreds of ... the same time substantially depress economic activity, according to ...
(Date:1/22/2015)... has released a new blog post presenting a list of vehicles ... , Some types of vehicles cannot be covered under an ... post to see if their vehicle qualifies for auto insurance coverage. ... the cars that cannot be covered by a plan. Clients have ...
Breaking Medicine News(10 mins):Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
... June 29, 2009 In the June issue of ... journal of the American Society for Gastrointestinal Endoscopy (ASGE), ... colonoscopy found a wide variation among endoscopists, though researchers ... reasons for the variation and their clinical significance. Also ...
... language development, study finds, , MONDAY, June 29 (HealthDay News) ... speech skills, UCLA researchers say, listening to what they have ... , The effect of a conversation between a child ... the effect of adult speech input alone, the researchers found. ...
... emergency departments first sites for savings measurement ... CalRHIO announced today that it has selected the RAND Corporation ... savings resulting from physicians having secure electronic access to critical ... first phase of the initiative will measure savings in emergency ...
... VANCOUVER, June 29 /PRNewswire-FirstCall/ - CRH Medical Corporation (CRM:TSX-V) ... College of Medicine in Mobile Alabama has completed ... Fellows on the non surgical removal of hemorrhoids using ... of this training program into its Fellowship Program, ...
... The July issue of European Urology , ... features an editorial by Lars Holmberg comparing the results ... Cancer (ERSPC) with the results from the Prostate, Lung, ... editorial, Professor Holmberg writes that "The studies illustrate that ...
... , JACKSONVILLE, Fla., June 29 On June ... the European Association for the Study of Diabetes investigated ... sanofi-aventis) and the development of certain malignancies. The authors ... their limited data and analyses, which precluded them from ...
Cached Medicine News:Health News:GIE: Gastrointestinal Endoscopy June issue study highlights 2Health News:GIE: Gastrointestinal Endoscopy June issue study highlights 3Health News:GIE: Gastrointestinal Endoscopy June issue study highlights 4Health News:GIE: Gastrointestinal Endoscopy June issue study highlights 5Health News:Talk With Kids, Not At Them 2Health News:Talk With Kids, Not At Them 3Health News:CalRHIO Selects RAND-USC to Evaluate Savings Resulting from Use of Statewide Health Information Exchange 2Health News:CalRHIO Selects RAND-USC to Evaluate Savings Resulting from Use of Statewide Health Information Exchange 3Health News:CRH Medical introduces non surgical hemorroid removal to Gastroenterology Fellowship program 2Health News:Prostate screening studies reviewed in European Urology July issue 2Health News:AACE Response to Insulin Glargine Cancer Risk Articles in Diabetologia 2
Sabre 180, 230V, 50Hz is a powerful niche generator....
... Excaliburplus PC, 100V, 50Hz/60Hz is the most powerful ... PTP in spray Coag. It is the only ... settings from the surgical field with a standard ... Voltage in CUT maintains minimum necessary voltage for ...
High performance capabilities in a multipurpose generator, blended cut modes, simultaneous independent coagulation, low voltage coagulation, valleylab REM safety substantially reduces the risk of pat...
The Valleylab Surgistat II generator provides exceptional performance, reliability, and safety benefits in a compact, easy to use unit....
Medicine Products: